Results 131 to 140 of about 106,775 (245)

Examining the Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on the Human Gut Microbiome: A Systematic Review [PDF]

Hezekiah C.T. Au, Kai Hei Fong, Yang Jing Zheng, Gia Han Le, Sabrina Wong, Kayla M. Teopiz, William W. L. Cheung, Kyle Valentino, Bing Cao, Heidi Ka Ying Lo, Roger Ho, Roger S. McIntyre   +11 more
openalex   +1 more source

New era for useful add-on therapy (AOT) to diabetes by combined agents of insulin and glucagon-like peptide-1 receptor agonist (GLP-1RA) [PDF]

, 2020
Hiroshi Bando
openalex   +1 more source

Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes. [PDF]

J Clin Med
Žaliukaitė G, Lebbar N.
europepmc   +1 more source

Distinct effects of dipeptidy1 peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist on islet morphology and function [PDF]

亜州華 森田
openalex  

Distribution of glucagon-like peptide 1 receptor and insulin in phaeochromocytomas. [PDF]

Endocr Connect
Følling I, Selle ML, Nilsen HR, Wennerström AB, Nilsen HL, Eide TJ.   +5 more
europepmc   +1 more source

Cardiorenal protective effects of glucagon-like peptide-1 receptor agonists in chronic kidney disease: a systematic review and meta-analysis

Yuqi Wang, LuDa Feng, Yajing Wang, Boyang Li, Ning Liang, Xuan Song, Jianguo Qin, Mianzhi Zhang, Yu Li   +8 more
openalex   +1 more source

A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus

, 2017
Hannah Botfield, Maria Uldall, Connar Stanley James Westgate, James Mitchell, Snorre Malm Hagen, Ana María Gonzalez, David J. Hodson, Rigmor Jensen, Alexandra J. Sinclair   +8 more
openalex   +2 more sources

Glucagon-Like Peptide-1 Receptor Agonists in Obesity-Induced Respiratory Pathophysiology. [PDF]

Acta Physiol (Oxf)
Ruiz MA, Furquim THDC, Davaanyam D, Williams NR, Polotsky VY, Amorim MR.   +5 more
europepmc   +1 more source

Cardioprotective mechanisms and effects of glucagon-like peptide-1 receptor agonists in autoimmune rheumatic diseases. [PDF]

Rheumatology (Oxford)
Karacabeyli D, Lacaille D.
europepmc   +1 more source

Vision impairment following glucagon-like peptide-1 receptor agonist use: is it harmful? [PDF]

Maria Cecilia Bahit, Michael K. Gibson, Martyna Kuleta, Łukasz Szarpak, Krzysztof Piotr Malinowski, Iwona Kowalska‐Bobko, Zbigniew Siudak   +6 more
openalex   +1 more source